Susquehanna International Group, LLP Gossamer Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$0.8 - $1.51 $25,840 - $48,773	32,300 Added 48.64%	98,700 $116,000
Q4 2023 Feb 14, 2024	SELL	$0.48 - $1.08 $27,168 - $61,128	-56,600 Reduced 46.02%	66,400 $60,000
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $85,644 - $199,836	109,800 Added 831.82%	123,000 $102,000
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.53 $131,222 - $204,867	-133,900 Reduced 91.03%	13,200 $15,000
Q1 2023 May 16, 2023	BUY	$0.96 - $2.92 $85,248 - $259,296	88,800 Added 152.32%	147,100 $185,000

Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $422,820 - $3.13 Million	-243,000 Reduced 80.65%	58,300 $126,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $359,058 - $741,024	-49,800 Reduced 14.18%	301,300 $3.61 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $188,055 - $314,055	-31,500 Reduced 8.23%	351,100 $2.94 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $2.96 Million - $4.38 Million	350,500 Added 1091.9%	382,600 $3.32 Million
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $467,543 - $650,034	-46,200 Reduced 59.0%	32,100 $363,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $388,600 - $709,128	53,600 Added 217.0%	78,300 $984,000
Q2 2021 Aug 11, 2021	SELL	$8.0 - $9.75 $134,400 - $163,800	-16,800 Reduced 40.48%	24,700 $201,000
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $50,054 - $63,452	5,800 Added 16.25%	41,500 $384,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $42,330 - $69,309	5,100 Added 16.67%	35,700 $345,000
Q3 2020 Nov 16, 2020	SELL	$11.3 - $14.75 $64,410 - $84,075	-5,700 Reduced 15.7%	30,600 $380,000
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $212,296 - $356,354	22,300 Added 159.29%	36,300 $472,000
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $224,280 - $314,580	14,000 New	14,000 $235,000

Others Institutions Holding GOSS

# of Institutions

114

Shares Held

190M

Call Options Held

405K

Put Options Held

490K

Nea Management Company, LLC Timonium, MD

15.8M
Shares

$14.3 Million
1.31% of portfolio
Artal Group S.A. Luxembourg, N4

13.3M
Shares

$12 Million
0.85% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$10.6 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

9.2M
Shares

$8.28 Million
0.31% of portfolio
Octagon Capital Advisors LP New York, NY

9.19M
Shares

$8.27 Million
1.7% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account